Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00338052
Status:
COMPLETED
Last Update Posted:
2008-05-08
First Post:
2006-06-16
Brief Title:
Study of Bleeding With Extended Administration of an Oral Contraceptive
Sponsor:
Warner Chilcott
Organization:
Warner Chilcott
Study Overview
Official Title:
Open-Label Study of Cycle Control With Extended Administration of Norethindrone Acetate 1 mg Ethinyl Estradiol 20 Mcg Oral Tablets
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an non-comparative study There is no statistical hypothesis The effects of extension of treatment on bleeding will be recorded and described
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None